Market Insights
The plasma therapy market was estimated at USD 409.84 million in 2022 and is likely to grow at a CAGR of 8.92% during 2023-2028 to reach USD 686.07 million in 2028.
Want to know more about the market scope? Register Here
What is Plasma and Plasma Therapy?
Plasma is the primary component of blood, accounting for more than half (about 55% of its total content). Plasma transports water, ions, and enzymes. The major role of plasma is to transport nutrients, hormones, and proteins to parts of the body that require them. Plasma therapy is a medical method that uses the blood of a healed patient to create antibodies against infected persons. Plasma therapy is most commonly utilized for wound healing, androgenetic alopecia, and face rejuvenation. Plasma therapy is used in the fields of dentistry, orthopedics, and dermatology.
Plasma Therapy Market Highlights
|
Market Size in 2022
|
USD 409.84 million
|
Market Size in 2028
|
USD 686.07 million
|
Market Growth (2023-2028)
|
8.92% CAGR
|
Base Year of Study
|
2022
|
Trend Period
|
2017-2021
|
Forecast Period
|
2023-2028
|
Market Dynamics
The rising number of sports injuries is propelling the worldwide plasma therapy market forward. The growing number of patients suffering from androgenic alopecia has contributed to the increased need for plasma therapy. The plasma therapy market is expanding rapidly as a result of the increasing use of platelet-rich plasma in several clinical sectors. Furthermore, greater consumer awareness about plasma donation is expected to strengthen the industry even further.
Platelet-rich plasma use is expanding as a result of increased involvement in sporting activities, which is leading to an increase in sports injuries and an increase in aesthetic surgery. Platelet-ri plasma (PRP) research applications are also supporting industry growth. For example, according to the American Society of Plastic Surgeons, there has been a 25% increase in the usage of PRP in cosmetics in the last four years.
In plastic surgery, platelet-rich plasma has evolved. It has shown promising outcomes when used to improve form and function by utilizing the body's own natural tissue repair mechanism. The main reasons for the increasing usage of PRP in therapies are its ease of use, low cost of production by employing the patient's cells, and low or no risk of adverse responses.
Platelet-rich plasma has numerous applications in skin rejuvenation, including improving skin texture and color and reducing wrinkle depth. Microneedling and topical PRP administration have been demonstrated to improve collagen generation and skin tightening for vampire facials. It is also being used to treat acne scars and skin pigmentation issues. PRP can bind to growth factors in hair transplants, increasing the proliferation of human hair.
PRP has shown promise in wound healing, bone growth in bisphosphonate-based osteonecrosis of the jaw, and soft tissue repair in the alveolar socket after tooth removal. Furthermore, medicinal variables are expected to offer a number of therapeutic expansion chances, boosting the market into the future.
Several investments/guidelines in the market have been directed in recent years, which would boost the overall market. Some of them are:
- Due to its robust research facilities for platelet-rich plasma, Germany held a significant revenue share in Europe in 2021. For example, in 2020, the 'Working Group for Clinical Tissue Generation' conducted a study that revealed the need for PRP preparation standardization and application methods for indications such as knee osteoarthritis.
Want to have a closer look at this market report? Click Here.
Segment Analysis
By Application Type
The plasma therapy market is segmented into orthopedics, dermatology, dental, cardiac muscle injury, nerve injury, and others. In 2022, the orthopedics section will have the highest revenue share. Other categories, however, such as dermatology, sports medicine, and ulcer healing, are predicted to increase at a profitable CAGR during the projection period. PRP has shown promising outcomes for the successful repair of chronic tendon injuries when compared to traditional therapies. PRP is useful in orthopedic therapy because it improves healing, tissue repair, and regeneration. Furthermore, PRP provides long-term comfort, soft tissue restoration, and bone reconstruction, resulting in market expansion.
The autogenous advantage of PRP-based treatment, researched safety profile, convenience of preparation, and lower cost of preparation have all contributed to growth in the sports medicine industry. Furthermore, it meets the need for quick recuperation so that athletes can return to the field, which promotes market growth.
Because of aesthetic operations and increased use in ulcer therapy, the dermatology segment is expected to rise at a quicker rate during the projection period. PRP-based microneedling in aesthetic operations has fueled market demand and will continue to do so. In the event of persistent ulcers, PRP treatment lowers ulcer size and cures ulcer wounds completely.
Regional Insights
The plasma therapy market is broken down geographically into geographies, namely North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In the past, and likely in the future, North America accounted for the largest share of the global market. Rapid medical facility expansion, expanding public knowledge of health issues, and rising demand are all factors contributing to this region's dominance. Furthermore, the large number of medical facilities and laboratories, as well as the rising target population, will help to this region's sustained dominance of the worldwide plasma therapy market over the forecast period.
The Asia Pacific market is expanding at a rapid pace. Each year, 10 lakh people in India suffer from moderate to severe burns, according to the WHO. The growing annual burn occurrence rate in India is driving wound care product sales. India has various potential opportunities in the medical sector. As a result, producers have a lot of room to expand in the Indian market. By 2025, the Indian government hopes to expand public health spending to 2.5% of GDP. A growing aged and diabetic population, as well as a developing healthcare infrastructure, are also driving market growth.
Know the high-growth countries in this report. Register Here.
Market Segmentation
This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.
The plasma therapy market is segmented into the following categories.
By Type
- Pure PRP
- Leucocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
By Application Type
- Orthopedics
- Dermatology
- Dental
- Cardiac Muscle Injury
- Nerve Injury
- Others
By End-User Type
- Hospitals
- Research Institutions
- Others
By Region
- North America (Country Analysis: The USA, Canada, and Mexico)
- Europe (Country Analysis: Germany, France, The UK, Russia, and The Rest of Europe)
- Asia-Pacific (Country Analysis: Japan, China, India, and the Rest of Asia-Pacific)
- Rest of the World (Country Analysis: Brazil, Argentina, and Others)
Click Here, to learn the market segmentation details.
Key Players
The following are the major players in the global market:
- Bio Products Laboratory Ltd.
- Arthrex
- Takeda Pharmaceutical Company Limited.
- Biotest AG.
- Cambryn Biologics
- China Biologic Products Holdings, Inc.
- CSL Limited
- DePuy Synthes
- Grifols, S.A.
- Kedrion S.p.A.
- Octapharma, Regen Lab SA
The global market is highly fragmented due to the huge number of active companies. Players are using a number of strategies to secure the top position, including mergers and acquisitions, joint ventures, and the development of fresh products. Furthermore, some companies are investing a lot of money in R&D projects and spreading their company's name throughout different areas in order to maintain a strong position in the general market rivalry. Below are a few key developments:
- Baxter International Inc. introduced PrisMax in the United States in July 2019 to maximize care for Critically Ill Patients. Patients with acute kidney damage (AKI) are given PrisMax. This rollout will help the company increase its income.
- Kamada Ltd. and Kedrion Biopharma will partner in April 2020 to develop a human plasma-derived Anti-SARs-COV-2 (COVID-19) polyclonal immunoglobulin (IgG) product for the treatment of coronavirus infection.
Research Methodology
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.
We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.
Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.
What Deliverables Will You Get in this Report?
Key questions this report answers
|
Relevant contents in the report
|
How big is the sales opportunity?
|
In-depth Analysis of the Plasma Therapy Market
|
How lucrative is the future?
|
Market forecast and trend data and emerging trends
|
Which regions offer the best sales opportunities?
|
Global, regional, and country-level historical data and forecasts
|
Which are the most attractive market segments?
|
Market Segment Analysis and Forecast
|
Which are the top players and their market positioning?
|
Competitive landscape analysis, Market share analysis
|
How complex is the business environment?
|
Porter’s five forces analysis, PEST analysis, Life cycle analysis
|
What are the factors affecting the market?
|
Drivers & challenges
|
Will I get the information on my specific requirements?
|
10% free customization
|
Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
- Detailed profiling of additional market players (up to three players)
- SWOT analysis of key players (up to three players)
Competitive Benchmarking
- Benchmarking of key players on the following parameters: product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research: Stratview Research offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@Stratviewresearch.com.